Trenaxa 500 Tablet

• Trenaxa 500 mg Tablet is used in the treatment of bleeding
• It is used to prevent or reduce bleeding for short period of time in conditions like heavy periods, dysfunctional uterine bleeding, nosebleed, tooth removal, after prostate surgery or after bladder surgery

• Side effects of Trenaxa Tablet.Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.Common side effects of Trenaxa.Musculoskeletal (bone, muscle or joint) pain.Joint pain.Headache.Back pain.Vomiting.Nausea.Abdominal pain.Fatigue.Diarrhea.Hypotension (low blood pressure).Sinus disorder.Anemia (low number of red blood cells).Allergic dermatitis.Lightheadedness.Thromboembolism

If you experience any persistent or severe side effects, consult your doctor immediately.

• How To Use Trenaxa Tablet.Take This Medicine In The Dose And Duration As Advised By Your Doctor. Swallow It As A Whole. Do Not Chew, Crush Or Break It. Trenaxa 500 Tablet Is To Be Taken With Food.

• How Trenaxa Tablet works.Trenaxa 500 Tablet is an anti-fibrinolytic. It works by preventing the breakdown of blood clots to control excessive bleeding during periods, or after surgery.

• 
  Alcohol:

  Trenaxa 500 Tablet may cause excessive drowsiness with alcohol.

• 
  Driving:

  Trenaxa 500 Tablet does not usually affect your ability to drive.

• 
  Kidney:

  Trenaxa 500 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Trenaxa 500 Tablet may be needed. Please consult your doctor.

• 
  Liver:

  Trenaxa 500 Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Trenaxa 500 Tablet may not be needed in these patients. Please consult your doctor.

• 
  Pregnancy:

  Information regarding the use of Trenaxa 500 Tablet during pregnancy is not available. Please consult your doctor.

• 
  Breastfeeding:

  Trenaxa 500 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.